Thomas D. Salus - 08 Jul 2025 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Chief Legal & Administration
Signature
/s/ Aaron S. Perlitsh, Attorney-In-Fact for Thomas D Salus
Issuer symbol
LFCR
Transactions as of
08 Jul 2025
Net transactions value
-$90,270
Form type
4
Filing time
10 Jul 2025, 16:45:45 UTC
Previous filing
16 Apr 2025
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Salus Thomas D. Chief Legal & Administration C/O LIFECORE BIOMEDICAL, INC., 3515 LYMAN BLVD., CHASKA /s/ Aaron S. Perlitsh, Attorney-In-Fact for Thomas D Salus 10 Jul 2025 0002062209

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Options Exercise +37,000 +17% 252,000 08 Jul 2025 Direct F1, F2
transaction LFCR Common Stock Tax liability $90,270 -11,022 -4.4% $8.19 240,978 08 Jul 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Performance-Based Restricted Stock Units Options Exercise -37,000 -10% 333,000 08 Jul 2025 Common Stock 37,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The performance-based restricted stock units vested based on the Issuer's achievement of a stock price milestone.
F2 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.
F3 Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the performance stock unit award as reported in Table I.